James I. Hudson, MD, ScD
- 10Articles
- 44.4KReads
- 2001–2020Active
- 37Collaborators
- 54Citations
About
James I. Hudson, MD, ScD, has published extensively on eating disorders, particularly binge-eating disorder and its treatment. His work includes clinical trials evaluating pharmacologic interventions such as dasotraline, atomoxetine, zonisamide, topiramate, citalopram, and fluoxetine in adults with binge-eating disorder, often in the context of obesity. Hudson has also explored the co-occurrence of binge-eating disorder with psychiatric and medical conditions, including fibromyalgia, and has investigated factors influencing dieting behaviors. His publications span from 2001 to 2020 in peer-reviewed psychiatric journals.
Publications
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
